پديد آورندگان :
Emamghorash F. نويسنده , Zendegani F. نويسنده , Rabiee S. نويسنده , Tagarod Z. نويسنده
چكيده لاتين :
Background: Neonatal jaun diceis clinically presented in 60%
of full-term newborns. About 8% of newborn s with j aundice
have urinary tract infection (UTI) without any other clinical
signs in favor of UTI. In present study we evaluated clinical and
paraclinical data that help to rapid and early diagnosis of UTI in
apparently healthy newborns with jaundice.
Methods: From February to August 2006, 51 apparently healthy
full-term newborns with ja undice and UTI who had been admitted
for management of jaundice in Motahary hospital, Jahrom
(south of Iran), were studied and compared with 56 neonates with
jaundi ce but without UTI. All the neonates had not any other
symptoms such as fever or lethargy. At the time of admission,
total and direct bilirubin, Coombsי test, mother and neonate blood
group, urinalysis and urine culture were requested.
Results: There was no significant difference of gestational
age, birth weight , age of admission, age at the time of starting
jaundice, and total serum bilirubin between the two groups.
There was s ignificant differ ence of dire ct bilirubin level, mean
of decrease serum bilirubin after 24 hours, gender, and blood
groups. Male gender with mean decrea se of bilirubin less than
2.2 mg/dl after 24 hours phototh erapy and direct bilirubin
more than 1.6 mg/dl ,during the first two weeks of neonatal
period has about 7 times more risk for UTI. The presence of
those three above mentioned factors had only 30% sensitivity
and more than 94% specificity for suspicious of UTI in asymptomatic
neonates with jaundice.
Conclusion: Jaundice may be the only presenting sign of UTI
in newborns, so according to high specificity for the presence
of three below factorss imultaneously, it seems better to
evalu ate newborns for UTI if they have high level of direct
bilirubin (more than J.6 mg/dl ), slow decrease in serum
bilirubin level with phototh erapy ( less than 2.2mg/dl/day) especi
ally in male newborn with blood group B.